Articles related to MOVEMENT DISORDERS

Gait speed tests assess functional mobility, providing insights into a patient’s ability to perform daily activities independently and safely.

Actigraphy devices revealed significant improvements in sleep patterns with nighttime levodopa use, despite patients not perceiving these changes subjectively.

Parkinson’s disease is increasingly recognized as a multisystem disorder, with nonmotor symptoms often preceding the classic motor signs by years or even decades.

A phase 3 clinical trial of buntanetap in early Parkinson’s disease patients demonstrated improvements in motor and cognitive functions, particularly in those with longer disease duration and postural instability.

Effective management of tardive dyskinesia requires early prevention with second-generation antipsychotics and the use of VMAT2 inhibitors like deutetrabenazine and valbenazine, which offer the highest quality evidence for reducing symptoms.

Non-invasive digital health tools, including wearable sensors and tremor-suppressing devices, are emerging as valuable adjuncts to traditional treatments for tremor management, significantly enhancing patient autonomy and quality of life.